SECsense Logo

Quoin Pharmaceuticals Ltd. 8-K Report: Key Insights & Securities Update

$QNRX
Form 8-K
Filed on: 2024-12-19
Source
Quoin Pharmaceuticals Ltd. 8-K Report: Key Insights & Securities Update

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: Quoin Pharmaceuticals Ltd.
  • CIK (Central Index Key): 0001671502
  • SEC File Type: 8-K
  • SEC File Number: 001-37846
  • EIN (Employer Identification Number): 92-2593104
  • Address: 42127 Pleasant Forest Court, Ashburn, VA 20148-7349
  • Contact Number: 703-980-4182
  1. Filing Date:
  • Date of Report: December 19, 2024
  1. Securities Information:
  • Type of Securities: American Depositary Shares (ADS)
  • ADS Representation: Each ADS represents one Ordinary Share
  • Ordinary Share Par Value: No par value
  • Ticker Symbol: QNRX
  • Exchange: NASDAQ
  1. Context Information:
  • Reporting Period: The report pertains to a specific date, December 19, 2024, indicating a snapshot of the company’s status on that day.
  1. Units of Measure:
  • The report mentions financial figures in USD (United States Dollars) and shares, indicating that the financial information is quantified in these units.
  1. Additional Information:
  • The report is structured using XBRL (eXtensible Business Reporting Language), which indicates that it's designed for digital reporting and may contain further detailed financial metrics not visible in this excerpt.

Summary:

Quoin Pharmaceuticals Ltd. filed an 8-K report with the SEC on December 19, 2024. The report includes details about the company, its securities (American Depositary Shares), and is prepared in a standardized digital format (XBRL). The company is listed under the ticker QNRX on NASDAQ.